Target Information
Abris Capital Partners ("Abris") has successfully completed the sale of Scanmed Group, the foremost privately-owned, diversified provider of in-patient care services in Poland, to American Heart of Poland on December 12, 2024. Abris initially invested in Scanmed Group in 2020, supporting its commitment to delivering high-quality healthcare. Scanmed Group operates over 30 facilities across Poland, catering to nearly 500,000 patients annually, and provides a broad spectrum of medical services, including primary care, outpatient specialist consultations, diagnostics, and inpatient treatments.
The company manages four multi-specialty hospitals: St. Raphael Hospital in Krakow, Rudolf Weigl Hospital in Blachownia, Vital Medic in Kluczbork, and Ars-Medical in Piła. In addition, Scanmed boasts 13 cardiac catheterization laboratories and three specialized inpatient clinics focusing on gastroenterology, ophthalmology, and orthopedics.
Industry Overview
Poland's healthcare industry has undergone significant transformation over recent years, marked by increased investment and a growing focus on improving service delivery standards. Despite facing challenges such as funding constraints and a rising demand for services due to an aging population, the sector remains poised for growth. The growing prominence of private healthcare providers, like Scanmed, has played a crucial role in bridging the service gap in the public healthcare system.
The Polish healthcare market is characterized by a mix of public and private entities, with private healthcare services witnessing an upward trend among patients seeking timely and high-quality treatment. The government has also implemented reforms aimed at enhancing health services and expanding access to quality healthcare across the country, which has further stimulated investment opportunities and innovation in the sector.
Moreover, the demand for specialized medical services has surged, driving the expansion of multi-specialty hospitals and private clinics. With increasing health awareness and technological advancements, patients are now more informed about their healthcare choices, fostering a competitive environment among medical service providers in Poland.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Rationale Behind the Deal
The acquisition of Scanmed by American Heart of Poland is strategically significant, as it enhances the latter's footprint in the Polish healthcare market. As a leading provider of comprehensive healthcare services, American Heart of Poland seeks to integrate Scanmed's established operations, expanding its service offerings and patient base. This transaction is anticipated to maximize operational efficiencies and improve healthcare delivery standards within the country.
Furthermore, the collaboration under the umbrella of Gruppo San Donato, esteemed for its expertise in acute care and medical research, empowers Scanmed to leverage state-of-the-art medical practices and advanced healthcare solutions, ultimately benefitting Polish patients.
Investor Information
American Heart of Poland is renowned for providing comprehensive, specialized healthcare services, merging health education, prevention, diagnosis, treatment, and rehabilitation across its facilities. It operates over 20 medical centers, serving more than 260,000 patients annually, offering high-caliber medical procedures aimed at improving patient outcomes.
The group falls under the ownership of Gruppo San Donato, a prominent European healthcare entity known for excelling in acute care, medical education, and research. Gruppo San Donato operates 136 medical establishments and is recognized for its leadership in gene and cell therapy, treating over 5.8 million patients annually with a workforce of more than 28,000 medical professionals.
View of Dealert
This acquisition presents a promising investment opportunity within the Polish healthcare landscape. Scanmed's established presence and quality services complement American Heart of Poland's strategic intent to enhance its operations and service offerings in the region. The integrated approach will likely result in improved healthcare outcomes and increased access to specialized medical services for patients.
The deal also holds the potential for fostering innovation and elevating service standards, as it brings together the extensive resources and expertise of American Heart of Poland and Gruppo San Donato with Scanmed's solid operational foundation. This union is anticipated to not only sustain but enhance the quality of care provided to patients, positively impacting the Polish healthcare system.
Overall, this investment reflects a well-considered move that aligns with the ongoing trend toward private healthcare growth in Poland, which is underpinned by increasing patient demand for high-quality medical services and the need for timely treatments.
Similar Deals
Abris Capital Partners → Ars Medical
2022
Abris Capital Partners → Scanmed S.A.
2020
Karo Healthcare → Perrigo’s Dermacosmetics portfolio
2026
INVL Private Equity Fund II, IFC, Accession Capital Partners → POLMED
2025
Management team of Sterimed, IK Partners, Sagard, Les Amis de Sterimed → Sterimed
2025
Capitala Group → Novellum Longevity
2025
Mable Health Inc. → The Medicus Group
2024
American Heart of Poland
invested in
Scanmed Group
in 2024
in a Management Buyout (MBO) deal